Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,919
Closed -$202K 1383
2021
Q1
$202K Buy
+1,919
New +$195K ﹤0.01% 1165
2019
Q4
Sell
-2,701
Closed -$215K 1205
2019
Q3
$215K Buy
2,701
+125
+5% +$9.82K ﹤0.01% 1030
2019
Q2
$215K Sell
2,576
-6
-0.2% -$478 ﹤0.01% 1046
2019
Q1
$204K Buy
+2,582
New +$188K ﹤0.01% 1052
2014
Q3
Sell
-13,130
Closed -$513K 874
2014
Q2
$513K Hold
13,130
0.03% 498
2014
Q1
$478K Buy
13,130
+185
+1% +$6.75K 0.03% 481
2013
Q4
$448K Buy
12,945
+90
+0.7% +$2.9K 0.02% 543
2013
Q3
$359K Sell
12,855
-500
-4% -$13.3K 0.02% 548
2013
Q2
$360K Buy
+13,355
New +$369K 0.02% 494

Other funds holding XYL

Stephens Inc's XYL Position: Q2 2021 in Review

Stephens Inc sold out of Xylem (XYL) in Q2 2021, closing a stake of 1,919 shares — an estimated $202K sold.

Stephens Inc first reported a position in XYL in Q2 2013 and held it in 9 quarters. The position peaked at $513K in Q2 2014. 773 funds tracked by Wall St. Rank hold XYL as of Q2 2021.

  • Stephens Inc reported no remaining Xylem position as of Q2 2021 after selling out during the quarter.
  • Stephens Inc sold 1,919 Xylem shares in Q2 2021, an estimated $202K.
  • Stephens Inc first reported a position in Xylem in Q2 2013 and held it in 9 quarters.
  • Stephens Inc's Xylem position peaked at $513K in Q2 2014.
  • 773 funds tracked by Wall St. Rank held Xylem as of Q2 2021.

Based on Stephens Inc's 13F filing for Q2 2021, filed 12 Aug 2021.